You may benefit from this test if you have:
Unexplained joint pain or arthritis
Chronic fatigue or frequent fevers
Persistent rashes or skin conditions
Weight loss without clear cause
Respiratory issues or lung conditions
Suspected autoimmune connective tissue disease
A family history of rheumatoid arthritis or lupus
Symptoms of chronic inflammation or vasculitis

Connective Tissue Disorder Panel

The Connective Tissue Disorders Panel is a comprehensive diagnostic tool designed to evaluate immune markers associated with autoimmune conditions such as rheumatoid arthritis, lupus, and scleroderma. Utilizing cutting-edge immunofluorescence and microarray technology, this panel helps detect early immune dysregulation and supports the clinical assessment of connective tissue-related disorders, guiding personalized management strategies.

Comprehensive Autoimmune Detection
  • Wide range of autoimmune markers linked to conditions like rheumatoid arthritis, lupus, and scleroderma, offering insights often missed by other tests.
  • Cutting-edge technology ensures superior accuracy in autoimmune disease detection.
Holistic Immune Health Monitoring
  • Identifies multiple autoimmune conditions simultaneously, providing a more comprehensive understanding of immune dysfunction.
  • Enables early diagnosis and faster treatment, improving long-term health outcomes.

Precision Testing You Can Trust

All of our laboratory tests are performed in a CLIA-certified and CAP-accredited facility in California

CMSWhite
HIPAAWhite

Why Order the Connective Tissue Disorder Test

WhyTest

If you’re experiencing joint pain, skin rashes, or fatigue, the Connective Tissue Disorders Panel can help. It detects key markers associated with autoimmune conditions like rheumatoid arthritis, lupus, and scleroderma, so you and your healthcare provider can pinpoint the cause of your symptoms.

The Connective Tissue Disorder Panel provides a detailed analysis of connective tissue integrity

Detects autoimmune and inflammatory markers linked to connective tissue disorders such as Ehlers-Danlos Syndrome (EDS), lupus, and rheumatoid arthritis. This test helps identify immune-mediated tissue damage, supporting personalized treatment strategies.
Box

About the Connective Tissue Disorder Panel

  • Vibrant™ RF IgM
  • Anti-CCP3 IgG/IgA

Vibrant Advantage

The Connective Tissue Disorder Panel provides a comprehensive evaluation of autoimmune conditions related to connective tissues, including lupus, rheumatoid arthritis, and scleroderma.

Identifies a wide range of autoantibodies associated with connective tissue diseases, offering early detection of conditions like lupus, rheumatoid arthritis, and systemic sclerosis.
Measures key markers of autoimmune activity, such as ANA, anti-dsDNA, and anti-CCP, which help identify the presence of autoimmune dysfunction early.
Provides valuable insights into chronic symptoms like joint pain, skin rashes, and fatigue, helping to guide personalized treatment for connective tissue disorders.
Early detection of connective tissue disorders enables timely intervention to prevent disease progression and manage long-term complications such as joint damage and organ dysfunction.

The Connective Tissue Disorder Panel is backed by clinical validation, ensuring reliable results that support optimal autoimmune disease management.

About the Connective Tissue Disorder Panel

Autoimmune Zoomer-Icon
Connective Tissue Disorder Panel
Why It Matters

The Connective Tissue Disorder Panel identifies autoimmune markers linked to conditions like lupus, rheumatoid arthritis, and scleroderma. Early detection of these markers helps to prevent long-term joint damage, skin issues, and systemic organ complications.

 

Key Insights

By identifying specific autoantibodies associated with connective tissue disorders, this test helps diagnose autoimmune diseases early, improving patient outcomes and enabling timely intervention to manage inflammation and prevent further damage.

What’s Measured

The Connective Tissue Disorder Panel measures autoantibodies such as ANA, anti-dsDNA, and anti-CCP, which are indicative of autoimmune activity affecting connective tissues.

Autoimmune Zoomer-Icon
Autoimmune Zoomer
Why It Matters

The Autoimmune Zoomer complements the Connective Tissue Disorder Panel by providing a broader spectrum of autoimmune markers. It helps uncover underlying immune dysfunctions that may be contributing to autoimmune diseases affecting connective tissues, providing a clearer path for personalized treatment.

Key Insights

The Autoimmune Zoomer identifies additional autoantibodies and antigens related to various autoimmune conditions, helping to detect and monitor immune system dysfunction that could impact connective tissues and other organs.

What’s Measured

The Autoimmune Zoomer measures a wide range of autoantibodies, including those for thyroid, insulin, and myelin, offering deeper insights into autoimmune responses that affect not only connective tissues but also other organ systems.

FAQs for Connective Tissue Disorder

The panel evaluates autoimmune markers, inflammatory markers, and specific antibodies associated with connective tissue diseases.

How it works

Process1-1
1

Order Your Test

Your wellness provider orders your lab test

Process2
2

Activate Your Kit

Scan the QR CODE to activate your kit.
Process3
3

Collect Your Sample

Follow the instructions included in your test kit to collect your sample.
Process4
4

Ship Immediately

Ship your sample to our lab team for analysis.
Process5
5

Receive Personalized Results

Receive your personalized report within 2-3 weeks.
Regulatory Statement
 
Limitations
Please note the information provided by Vibrant Wellness is intended solely for research and informational purposes to help inform lifestyle choices aimed at potential risk mitigation. The information is not intended to be used by the patient for any diagnostic purpose and is not a substitute for medical advice by a healthcare practitioner. Please consult a licensed healthcare practitioner for any questions regarding diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of the health of, human beings. The tests listed on web page titled “New York State Approved Tests” can be used for diagnostic purposes are per their intended use.
 
Regulatory Disclaimer
Please note the information provided by Vibrant Wellness is intended solely for research and informational purposes to help inform lifestyle choices aimed at potential risk mitigation. The tests were developed, and their performance characteristics were determined by Vibrant America and Vibrant Genomics. They have not been cleared or approved by US Food and Drug Administration. The laboratory is certified under the Clinical Laboratory Improvements Amendments (CLIA) as qualified to perform high complexity testing. The laboratory is also in compliance with College of American Pathologists (CAP) regulations. The tests listed on web page titled “New York State Approved Tests” are cleared by FDA and also comply with the New York State Department of Health regulations.